Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02762032
PHASE1

Natreon Healthy Skin Study - PrimaVie Supplement

Sponsor: Ohio State University

View on ClinicalTrials.gov

Summary

This study will demonstrate the ability of the oral supplement, PrimaVie® to improve skin microperfusion, hydration, elasticity and barrier function. 45 females will be enrolled in 1 of 3 arms where they will receive either 125 mg PrimaVie, 250 mg PrimaVie or placebo (control) to take twice daily for 14 weeks.

Official title: The Ability of an Oral Supplement to Improve Skin Microperfusion, Hydration, Elasticity, and Barrier Function

Key Details

Gender

FEMALE

Age Range

30 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2016-02-20

Completion Date

2019-12-20

Last Updated

2026-06-25

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

PrimaVie Herbal Supplement 125

125 mg to take BID for 14 weeks in Arm 1

DIETARY_SUPPLEMENT

PrimaVie Herbal Supplement 250

250 mg to take BID for 14 weeks in Arm 2

DRUG

Placebo

Placebo supplement to take BID for 14 weeks in Arm 3

Locations (3)

OSU Hospital East

Columbus, Ohio, United States

Davis Heart and Lung Research Institute

Columbus, Ohio, United States

Martha Morehouse Medical Plaza 2050 Kenny Road

Columbus, Ohio, United States